Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection
Daniele De Filippis(University of Naples Federico II), Teresa Iuvone(University of Naples Federico II), Giuseppe Esposito(Sapienza University of Rome), Mariateresa Cipriano(Federico II University Hospital), Antonio Steardo(University of Salerno), Caterina Scuderi(Sapienza University of Rome), Alessandra D’Amico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 15
Related Papers
The Spice Sage and Its Active Ingredient Rosmarinic Acid Protect PC12 Cells from Amyloid-β Peptide-Induced Neurotoxicity
|Journal of Pharmacology and Experimental Therapeutics|2006|236
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
|Pharmacological Research|2022|146
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease
|Cell Death and Disease|2014|100